FDA New Drug Approval Process; with Stephen G. Marcus, M.D.

from DoctorPodcasts || Cykiert Files · host Robert Cykiert, M.D. - Physician creator, writer, producer, director and host.

DoctorPodcasts EPISODE 61: #FDA approval of a new drug is a complex, rigorous, lengthy, expensive but necessary process. Find out how it's done from Stephen G. Marcus, M.D., CEO of Cantex Pharmaceuticals. Dr. Marcus is running clinical trials of potential blockbuster drug AZELIRAGON http://Cantex.com/pipeline for treating various cancers and kidney disease caused by pneumonia infections. For a Directory of all the other #DoctorPodcasts episodes, go to https://www.doctorpodcasts.com/index-of-doctorpodcasts-episodes/

Episode metadata supplied by the publisher feed · Published Aug 13, 2024

Embed this episode

Attribution link and audio player

Ready to play

FDA New Drug Approval Process; with Stephen G. Marcus, M.D.

0:00 50:23

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of DoctorPodcasts || Cykiert Files?

This episode is 50 minutes long.

When was this DoctorPodcasts || Cykiert Files episode published?

This episode was published on August 13, 2024.

Can I download this DoctorPodcasts || Cykiert Files episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!